English | Español

Biospace
Patient Daily | Feb 23, 2026

Four late-stage drugs attract industry attention after Rezdiffra's success
Patient Daily | Feb 22, 2026

Ionis expands commercial presence after strong initial launch of Tryngolza
Patient Daily | Feb 22, 2026

Patent strategies delay entry of generic drugs and keep prices high
Patient Daily | Feb 22, 2026

Korsana launches with $150M series A to develop new Alzheimer’s antibody
Patient Daily | Feb 22, 2026

FDA agrees to review Moderna's mRNA flu vaccine after initial refusal
Patient Daily | Feb 22, 2026

Regulatory shifts at FDA raise risks for drug developers and investors
Patient Daily | Feb 22, 2026

FDA’s shift from animal testing highlights role of AI and organoids in drug development
Patient Daily | Feb 22, 2026

Ocular Therapeutix’s hydrogel shows stronger results than Eylea in late-stage wet AMD trial

Trending
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Regulatory
Patient Daily | Mar 9, 2026

Pharmacy owner Kiefer on PBMs: 'Independent pharmacies are being aggressively pushed out of business by the monopolistic practices of PBMs'
+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research